Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with a multifactorial pathophysiology. The gut microbiota differs between patients with IBS and healthy individuals. After a bout of acute gastroenteritis, postinfection IBS may result in up to approximately 10% of those...

Descripción completa

Detalles Bibliográficos
Autores principales: Chey, William D., Shah, Eric D., DuPont, Herbert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984424/
https://www.ncbi.nlm.nih.gov/pubmed/32047534
http://dx.doi.org/10.1177/1756284819897531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984424/
https://www.ncbi.nlm.nih.gov/pubmed/32047534
http://dx.doi.org/10.1177/1756284819897531

Ejemplares similares